Cardiometabolic Candidate Endotypes in Psoriatic Disease: Integration of Clinical, Metabolic, and Immunogenetic Data Across Psoriasis and Psoriatic Arthritis

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background/objectives: Psoriatic disease (PsD) encompasses psoriasis (PsO) and psori-atic arthritis (PsA) and is associated with heterogeneous cardiometabolic risk. Inte-grating immunogenetic markers such as HLA-Cw6 into data-driven analyses may re-fine phenotyping and uncover clinically meaningful endotypes. We aimed to identify cardiometabolic phenotypes across PsD, integrating HLA-Cw6 and exploring dis-ease-specific heterogeneity and predictors of high-risk profiles. Methods: In a cross-sectional study of 572 PsD patients (401 PsO, 171 PsA), eight demographic and clinical variables including HLA-Cw6 were entered into k-means clustering (k = 4). Cardiometabolic risk factors were profiled post hoc. Cluster validity was assessed by Gaussian Mixture Models and principal component analysis (PCA). Stratified analyses (k = 3) were conducted separately for PsO and PsA. Predictors of the high-risk pheno-type were examined using bootstrap-resampled logistic regression. Results: Four global clusters were identified, ranging from inflammation-dominant/low-risk to a small high-risk group (C4, 5.8 %). C4 combined older age (median 66 years) with universal CVD and the highest prevalence of hypertension (75.8 %) and dyslipidemia (69.7 %). PCA confirmed two dominant orthogonal axes: cardiometabolic and inflammato-ry/immunogenetic. Validation showed high concordance (adjusted Rand index 0.83). In stratified analyses, HLA-Cw6 showed opposite associations—enriched in high-risk PsO (OR 2.0, 95 % CI 1.3–3.1) but depleted in high-risk PsA (OR 0.24, 95 % CI 0.11–0.52). Conclusions: Incorporating HLA-Cw6 into clustering identified reproducible cardiometabolic phenotypes with distinct genetic signatures. The inverse HLA Cw6–risk patterns in PsO and PsA suggest disease-specific endotypes with differing cardi-ometabolic trajectories, supporting genetic–clinical integration for targeted prevention.

Article activity feed